TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,288 | -8.8% | 665 | -7.4% | 0.00% | 0.0% |
| Q2 2023 | $11,280 | +21.1% | 718 | +27.1% | 0.00% | +100.0% |
| Q1 2023 | $9,312 | +5.7% | 565 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,814 | +25.9% | 565 | +12.3% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -41.7% | 503 | -39.3% | 0.00% | -50.0% |
| Q2 2022 | $12,000 | 0.0% | 828 | -0.5% | 0.00% | 0.0% |
| Q1 2022 | $12,000 | +33.3% | 832 | +29.6% | 0.00% | +100.0% |
| Q4 2021 | $9,000 | -18.2% | 642 | -2.3% | 0.00% | -50.0% |
| Q3 2021 | $11,000 | +37.5% | 657 | +31.9% | 0.00% | +100.0% |
| Q2 2021 | $8,000 | -33.3% | 498 | -25.4% | 0.00% | -50.0% |
| Q1 2021 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $12,000 | 0.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $12,000 | +20.0% | 668 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | -23.1% | 668 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $13,000 | – | 668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |